Citations (44)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Haoran He, Jiaming Wu, Min Liang, Yao Xiao, Xuejian Wei, Yuqin Cao, Zhiheng Chen, Tian Lin & Miaosheng Ye. (2022) Cuprous oxide-based nanocrystals with combined chemo/chemodynamic therapy to increase tumor drug sensitivity by reducing mitochondria-derived adenosine-triphosphate. Drug Delivery 29:1, pages 3134-3141.
Read now
Read now
Shadab Md, Nabil A. Alhakamy, Priyanka Sharma, Mohammad Shahnawaze Ansari & Bapi Gorain. (2022) Nanocarrier-based co-delivery approaches of chemotherapeutics with natural P-glycoprotein inhibitors in the improvement of multidrug resistance cancer therapy. Journal of Drug Targeting 30:8, pages 801-818.
Read now
Read now
Ayala Bar-Hai, Abraham J. Domb & Amnon Hoffman. (2022) Strategies for enhancing the oral bioavailability of cannabinoids. Expert Opinion on Drug Metabolism & Toxicology 18:5, pages 313-322.
Read now
Read now
Chenglong Wang, Xuzhu Gao, Fanchen Wang, Wencai Guan, Hongjing Dou & Guoxiong Xu. (2020) Effect of Starvation in Reversing Cancer Chemoresistance Based on Drug-Resistance Detection by Dextran Nanoparticles. International Journal of Nanomedicine 15, pages 9255-9264.
Read now
Read now
Articles from other publishers (40)
Jéssica Veiga-Matos, Ana I. Morales, Marta Prieto, Fernando Remião & Renata Silva. (2023) Study Models of Drug–Drug Interactions Involving P-Glycoprotein: The Potential Benefit of P-Glycoprotein Modulation at the Kidney and Intestinal Levels. Molecules 28:22, pages 7532.
Crossref
Crossref
Alicja Jakimiuk, Agnieszka Piechal, Alicja Wiercińska-Drapało, Alicja Nowaczyk & Dagmara Mirowska-Guzel. (2023) Central nervous system disorders after use of dolutegravir: evidence from preclinical and clinical studies. Pharmacological Reports.
Crossref
Crossref
Chunyu Jiang, Ting Pan, Yunxiang Jiang, Zhiyu Zhang, Meifeng Zeng, Shuang Sun, Zheng Li, Yiqing Wu, Jingying Qiu, Mingshan Niu & Xiaoke Gu. (2023) Design and evaluation of dibenzoazepine-tetrahydroisoquinoline hybrids as potential P-glycoprotein inhibitors against multidrug resistant K562/A02 cells. European Journal of Medicinal Chemistry 249, pages 115150.
Crossref
Crossref
Wenqin Sun, Iris L. K. Wong, Helen Ka-Wai Law, Xiaochun Su, Terry C. F. Chan, Gege Sun, Xinqing Yang, Xingkai Wang, Tak Hang Chan, Shengbiao Wan & Larry M. C. Chow. (2023) In Vivo Reversal of P-Glycoprotein-Mediated Drug Resistance in a Breast Cancer Xenograft and in Leukemia Models Using a Novel, Potent, and Nontoxic Epicatechin EC31. International Journal of Molecular Sciences 24:5, pages 4377.
Crossref
Crossref
Xiaolin Zhang, Lanlan Jia, Nanxin Liu, Ying Zhao, Tingting Zhang & Xiaoyu Xie. (2023) Inside-out extracellular vesicles-like biomimetic magnetic nanoparticles for efficient screening P-Glycoprotein inhibitors to overcome cancer multidrug resistance. Colloids and Surfaces B: Biointerfaces 222, pages 113134.
Crossref
Crossref
Maria Pia Adorni, Maricla Galetti, Silvia La Monica, Matteo Incerti, Alessandro Ruffoni, Lisa Elviri, Ilaria Zanotti, Bianca Papotti, Delia Cavallo, Roberta Alfieri, Pier Giorgio Petronini & Franco Bernini. (2023) A New ABCB1 Inhibitor Enhances the Anticancer Effect of Doxorubicin in Both In Vitro and In Vivo Models of NSCLC. International Journal of Molecular Sciences 24:2, pages 989.
Crossref
Crossref
Susan Miller, Walter Moos, Barbara Munk, Stephen Munk, Charles Hart & David Spellmeyer. 2023. Managing the Drug Discovery Process. Managing the Drug Discovery Process
207
338
.
Karolina Dżaman & Katarzyna Czerwaty. (2022) Roles of Exosomes in Chronic Rhinosinusitis: A Systematic Review. International Journal of Molecular Sciences 23:19, pages 11284.
Crossref
Crossref
Ewa Żesławska, Waldemar Tejchman, Annamária Kincses, Gabriella Spengler, Wojciech Nitek, Grzegorz Żuchowski & Ewa Szymańska. (2022) 5-Arylidenerhodanines as P-gp Modulators: An Interesting Effect of the Carboxyl Group on ABCB1 Function in Multidrug-Resistant Cancer Cells. International Journal of Molecular Sciences 23:18, pages 10812.
Crossref
Crossref
Aya M. Kelly, Matthew R. Berry, Sarah Z. Tasker, Sydney A. McKee, Timothy M. Fan & Paul J. Hergenrother. (2022) Target-Agnostic P-Glycoprotein Assessment Yields Strategies to Evade Efflux, Leading to a BRAF Inhibitor with Intracranial Efficacy. Journal of the American Chemical Society 144:27, pages 12367-12380.
Crossref
Crossref
Yuhong Cao, Jiahao Fang, Yiwei Shi, Hui Wang, Xiaofei Chen, Yue Liu, Zhenyu Zhu, Yan Cao, Zhanying Hong & Yifeng Chai. (2022) Screening potential P-glycoprotein inhibitors by combination of a detergent-free membrane protein extraction with surface plasmon resonance biosensor. Acta Pharmaceutica Sinica B 12:7, pages 3113-3123.
Crossref
Crossref
Athar Husain, Vishal Makadia, Guru R. Valicherla, Mohammed Riyazuddin & Jiaur R. Gayen. (2022) Approaches to minimize the effects of P‐glycoprotein in drug transport: A review. Drug Development Research 83:4, pages 825-841.
Crossref
Crossref
Meshal Alshamrani, Navid J. Ayon, Abdullah Alsalhi & Omowumi Akinjole. (2022) Self-Assembled Nanomicellar Formulation of Docetaxel as a Potential Breast Cancer Chemotherapeutic System. Life 12:4, pages 485.
Crossref
Crossref
Leah Davis, Matthias Recktenwald, Evan Hutt, Schuyler Fuller, Madison Briggs, Arnav Goel & Nichole Daringer. (2022) Targeting HIF-2α in the Tumor Microenvironment: Redefining the Role of HIF-2α for Solid Cancer Therapy. Cancers 14:5, pages 1259.
Crossref
Crossref
Prasad NEERATI & Sangeethkumar MUNIGADAPA. (2022) Novel Indole Derivative as the First P-glycoprotein Inhibitor from the Skin of Indian Toad <i>(Bufo melanostictus)</i>. Turkish Journal of Pharmaceutical Sciences 19:1, pages 63-69.
Crossref
Crossref
Xiaoying Jiang, Kaiyu Wu, Renren Bai, Pengfei Zhang & Yi Zhang. (2022) Functionalized quinoxalinones as privileged structures with broad-ranging pharmacological activities. European Journal of Medicinal Chemistry 229, pages 114085.
Crossref
Crossref
Sepideh Mirzaei, Mohammad Hossein Gholami, Farid Hashemi, Amirhossein Zabolian, Mahdi Vasheghani Farahani, Kiavash Hushmandi, Ali Zarrabi, Aaron Goldman, Milad Ashrafizadeh & Gorka Orive. (2022) Advances in understanding the role of P-gp in doxorubicin resistance: Molecular pathways, therapeutic strategies, and prospects. Drug Discovery Today 27:2, pages 436-455.
Crossref
Crossref
Qian Huang, Xun Liu, Haiyang Wang, Xiangrui Liu, Qianzhi Zhang, Ke Li, Yu Chen, Qian Zhu, Youqing Shen & Meihua Sui. (2022) A nanotherapeutic strategy to overcome chemoresistance to irinotecan/7-ethyl-10-hydroxy-camptothecin in colorectal cancer. Acta Biomaterialia 137, pages 262-275.
Crossref
Crossref
Xi Yang, Yuzhong Peng, Yufei He, Xuejun Huang, Aili Xu, Xiaoli Bi & Ying Xie. (2021) P-glycoprotein mediated interactions between Chinese materia medica and pharmaceutical drugs. Digital Chinese Medicine 4:4, pages 251-261.
Crossref
Crossref
Xu Cheng, Dapeng Li, Jiaxi Xu, Bing Wei, Qin Fang, Longshun Yang, Yanbing Xue, Xin Wang & Rupei Tang. (2021) Self-assembled ternary hybrid nanodrugs for overcoming tumor resistance and metastasis. Acta Pharmaceutica Sinica B 11:11, pages 3595-3607.
Crossref
Crossref
Xinguang Cao, Rui Li, Huihua Xiong, Jinfang Su, Changqing Guo, Tianqi An, Hong Zong & Ruihua Zhao. (2021) Novel Pt(IV) complexes to overcome multidrug resistance in gastric cancer by targeting P-glycoprotein. European Journal of Medicinal Chemistry 221, pages 113520.
Crossref
Crossref
Suree Jianmongkol. 2021. Advances in Precision Medicine Oncology. Advances in Precision Medicine Oncology.
Thi-Thao-Linh Nguyen, Van-An Duong & Han-Joo Maeng. (2021) Pharmaceutical Formulations with P-Glycoprotein Inhibitory Effect as Promising Approaches for Enhancing Oral Drug Absorption and Bioavailability. Pharmaceutics 13:7, pages 1103.
Crossref
Crossref
Chung-Pu Wu, Megumi Murakami, Yu-Shan Wu, Ya-Chen Chi, Sung-Han Hsiao, Yang-Hui Huang, Tai-Ho Hung & Suresh V. Ambudkar. (2021) Branebrutinib (BMS-986195), a Bruton’s Tyrosine Kinase Inhibitor, Resensitizes P-Glycoprotein-Overexpressing Multidrug-Resistant Cancer Cells to Chemotherapeutic Agents. Frontiers in Cell and Developmental Biology 9.
Crossref
Crossref
Zhaoshi Bai, Qing Zhou, Huayun Zhu, Xinyue Ye, Pingping Wu & Lingman Ma. (2021) QTMP, a Novel Thiourea Polymer, Causes DNA Damage to Exert Anticancer Activity and Overcome Multidrug Resistance in Colorectal Cancer Cells. Frontiers in Oncology 11.
Crossref
Crossref
V. V. Dlin & S. L. Morozov. (2021) Personalized therapy in pediatric nephrology: Problems and prospects. Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics) 66:2, pages 6-12.
Crossref
Crossref
Bastian Haberkorn, Martin F. Fromm & Jörg König. (2021) Transport of Drugs and Endogenous Compounds Mediated by Human OCT1: Studies in Single- and Double-Transfected Cell Models. Frontiers in Pharmacology 12.
Crossref
Crossref
Yuhong Cao, Yan Cao, Yiwei Shi, Ying Cai, Langdong Chen, Dongyao Wang, Yue Liu, Xiaofei Chen, Zhenyu Zhu, Zhanying Hong & Yifeng Chai. (2021) Surface plasmon resonance biosensor combined with lentiviral particle stabilization strategy for rapid and specific screening of P-Glycoprotein ligands. Analytical and Bioanalytical Chemistry 413:7, pages 2021-2031.
Crossref
Crossref
S. L. Morozov, A. S. Voronkova & V. V. Dlin. (2021) The value of ABCB1 gene expression in children with idiopathic nephrotic syndrome. Nephrology (Saint-Petersburg) 25:1, pages 83-89.
Crossref
Crossref
Małgorzata Anna Marć, Annamária Kincses, Bálint Rácz, Muhammad Jawad Nasim, Muhammad Sarfraz, Carlos Lázaro-Milla, Enrique Domínguez-Álvarez, Claus Jacob, Gabriella Spengler & Pedro Almendros. (2020) Antimicrobial, Anticancer and Multidrug-Resistant Reversing Activity of Novel Oxygen-, Sulfur- and Selenoflavones and Bioisosteric Analogues. Pharmaceuticals 13:12, pages 453.
Crossref
Crossref
Marialessandra Contino, Stefano Guglielmo, Chiara Riganti, Giulia Antonello, Maria Grazia Perrone, Roberta Giampietro, Barbara Rolando, Roberta Fruttero & Nicola A. Colabufo. (2020) One molecule two goals: A selective P-glycoprotein modulator increases drug transport across gastro-intestinal barrier and recovers doxorubicin toxicity in multidrug resistant cancer cells. European Journal of Medicinal Chemistry 208, pages 112843.
Crossref
Crossref
Xiaoke Gu, Xin Li, Mingyu Guan, Chunyu Jiang, Qinghua Song, Nan Sun, Yueting Zou, Qingqing Zhou, Jing Chen & Jingying Qiu. (2020) Discovery of thiosemicarbazone-containing compounds with potent anti-proliferation activity against drug-resistant K562/A02 cells. Bioorganic & Medicinal Chemistry Letters 30:24, pages 127638.
Crossref
Crossref
Kathryn Dzintars & Lindsey P. Toman. (2020) Interpretation and Understanding of Clinical Drug Interactions Between Azoles and Immunosuppressants in Solid Organ Transplant Recipients. Current Fungal Infection Reports 14:4, pages 391-396.
Crossref
Crossref
Yuhong Cao, Yiwei Shi, Ying Cai, Zhanying Hong & Yifeng Chai. (2020) The Effects of Traditional Chinese Medicine on P-Glycoprotein–Mediated Multidrug Resistance and Approaches for Studying the Herb–P-Glycoprotein Interactions. Drug Metabolism and Disposition 48:10, pages 972-979.
Crossref
Crossref
Milad Ashrafizadeh, Ali Zarrabi, Kiavash Hushmandi, Mahshad Kalantari, Reza Mohammadinejad, Tahereh Javaheri & Gautam Sethi. (2020) Association of the Epithelial–Mesenchymal Transition (EMT) with Cisplatin Resistance. International Journal of Molecular Sciences 21:11, pages 4002.
Crossref
Crossref
Ying-Tzu Chang, Yu-Chao Lin, Lijuan Sun, Wei-Chieh Liao, Charles C.N. Wang, Che-Yi Chou, Susan L. Morris-Natschke, Kuo-Hsiung Lee & Chin-Chuan Hung. (2020) Wilforine resensitizes multidrug resistant cancer cells via competitive inhibition of P-glycoprotein. Phytomedicine 71, pages 153239.
Crossref
Crossref
Joanna Kopecka, Martina Godel, Silvia Dei, Roberta Giampietro, Dimas Carolina Belisario, Muhlis Akman, Marialessandra Contino, Elisabetta Teodori & Chiara Riganti. (2020) Insights into P-Glycoprotein Inhibitors: New Inducers of Immunogenic Cell Death. Cells 9:4, pages 1033.
Crossref
Crossref
Subhash D. Tanpure, Mohamed F. El-Mansy & Paul R. Blakemore. (2020)
Synthesis of a P-Glycoprotein Inhibitor and Its High-Energy (
Z
)-Isomer by Carbenoid Eliminative Cross-Coupling
. Organic Letters 22:8, pages 2999-3003.
Crossref
Crossref
Yu-Ning Teng, Charles C.N. Wang, Wei-Chieh Liao, Yu-Hsuan Lan & Chin-Chuan Hung. (2020) Caffeic Acid Attenuates Multi-Drug Resistance in Cancer Cells by Inhibiting Efflux Function of Human P-Glycoprotein. Molecules 25:2, pages 247.
Crossref
Crossref
Chung-Pu Wu, Sabrina Lusvarghi, Jyun-Cheng Wang, Sung-Han Hsiao, Yang-Hui Huang, Tai-Ho Hung & Suresh V. Ambudkar. (2019) The Selective Class IIa Histone Deacetylase Inhibitor TMP195 Resensitizes ABCB1- and ABCG2-Overexpressing Multidrug-Resistant Cancer Cells to Cytotoxic Anticancer Drugs. International Journal of Molecular Sciences 21:1, pages 238.
Crossref
Crossref